Pei Tsai

DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes

Sara B. Willett, Vickie Hsuan, T. Pesaran, 2018, Genetics in Medicine.

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

E. Plimack, Vickie Hsuan, R. Mehra, 2016, Oncotarget.

TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome

Sitao Wu, M. Janicek, H. Rana, 2018, Oncotarget.

Correction: DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes

Vickie Hsuan, T. Pesaran, Wenbo Mu, 2018, Genetics in Medicine.